Certara vs Health Catalyst
Certara reported revenue of $419 million in fiscal 2025, 1.3 times Health Catalyst's $311 million in fiscal 2025. Certara's revenue grew 8.8% in its latest year, and Health Catalyst's grew 1.5%. Certara had an operating margin of 5.0%, against -51.7% at Health Catalyst. Free cash flow was $95 million at Certara and −$0 million at Health Catalyst.
Side by side
| Certara | Health Catalyst | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $419M | $311M |
| Revenue growth | 8.8% | 1.5% |
| Revenue growth a year, last 5 years | 11.5% | 10.5% |
| Gross margin | — | — |
| Operating margin | 5.0% | −51.7% |
| Net margin | −0.4% | −57.2% |
| Free cash flow | $95M | −$0M |
| Free cash flow margin | 22.6% | −0.1% |
| Return on capital | 0.9% | −38.6% |
| Net debt to EBITDA | 1.1x | — |
| Dividends and buybacks | $43M | $5M |
| Change in diluted share count | 0.0% | 16.1% |
| Last close | $10.68 | $1.29 |
| P/E at the last close | — | — |
| Insider trades, last 12 months | — | bought $105,610, sold $200,554 |
| Piotroski F-score | 5 of 8 | 4 of 8 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
CertaraHealth Catalyst
Operating margin
Percent of revenue
CertaraHealth Catalyst
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
CertaraHealth Catalyst
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Certara and Health Catalyst pages.